CARULLO GABRIELE

Gabriele
Carullo
Ricercatore Legge 240/10 - tempo determinato

Presentation

Dr. Gabriele Carullo is a tenure track researcher (RTDB) in Medicinal Chemistry (Italian scientific sector CHIM/08), and carries out research activities mainly interested in:

  • development of pharmacological tools for the treatment of rare diseases
  • synthesis and optimization of epigenetic modulators for the treatment of tumors
  • extractive preparations from plant matrices using green techniques, analysis and study of nutraceutical properties

Teaching activities

Completion accademic year: 2025/2026

Course year: 1 Second cycle degree (Laurea Magistrale) CHEMISTRY FOR AGRIFOOD A.Y. 2025/2026
Course year: 5 Full cicle (5 years) PHARMACY A.Y. 2021/2022

Completion accademic year: 2024/2025

Course year: 1 Second cycle degree (Laurea Magistrale) CHEMISTRY FOR AGRIFOOD A.Y. 2024/2025

Completion accademic year: 2023/2024

Course year: 3 Full cicle (5 years) PHARMACY A.Y. 2021/2022

Research

Ultime pubblicazioni:

  • Rossi, S., Pozzetti, L., Carullo, G., Dichiara, M., Butini, S., Radi, M., et al. (2025). Discovery of p-Trifluoromethylbenzohydrazide Derivatives as Potent Antiviral Agents against Monkeypox Virus. ACS MEDICINAL CHEMISTRY LETTERS, 16(5), 837-843 [10.1021/acsmedchemlett.5c00075]. - view more
  • Rossi, S., Deidda, G., Fiaschi, L., Ibba, R., Pieroni, M., Dichiara, M., et al. (2025). Synthesis and biological investigation of peptidomimetic SARS‐CoV‐2 main protease inhibitors bearing quinoline‐based heterocycles at P3. ARCHIV DER PHARMAZIE, 358(1) [10.1002/ardp.202400812]. - view more
  • Cursaro, I., Ciccone, V., Tudino, V., Papulino, C., Scalvini, L., Donnini, S., et al. (2025). Reversing TGF-β1-induced fibrotic phenotype in human lung fibroblasts using a PROTAC tool derived from an indoline-based HDAC6 inhibitor. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY REPORTS, 14 [10.1016/j.ejmcr.2025.100276]. - view more
  • Falbo, F., Gemma, S., Koch, A., Mazzotta, S., Carullo, G., Ramunno, A., et al. (2024). Synthetic derivatives of natural cinnamic acids as potential anti-colorectal cancer agents. CHEMICAL BIOLOGY & DRUG DESIGN, 103(1) [10.1111/cbdd.14415]. - view more
  • Pessina, F., Casini, I., Gamberucci, A., Carullo, G., Signorini, C., Brizzi, A., et al. (2024). Anti-Inflammatory and Antinociceptive Properties of the Quercetin-3-Oleate AV2, a Novel FFAR1 Partial Agonist. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 25(21) [10.3390/ijms252111635]. - view more